Literature DB >> 24953398

Apolipoprotein B and apolipopotein A-I in vascular risk prediction - a review.

C Schmidt, G Bergstrom1.   

Abstract

The concentration of low-density lipoprotein cholesterol has long been generally accepted as one of the strongest, independent risk factors for the development of cardiovascular disease. However, an increasing number of studies suggest that the ratio of apolipoprotein B (apoB) to apolipoprotein A-I (apoA-I) is a better risk predictor. In the present review, we focus on apoB and apoA-I as factors in predicting vascular risk in epidemiological studies only, and not in studies involving pharmaceutical intervention. The majority of studies in the present review show that apoB and the apoB/apoA-I ratio are independently and more strongly associated with vascular risk across varying age-groups and geographic regions than are conventional lipids, lipoproteins and lipid ratios.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24953398     DOI: 10.2174/1381612820666140620121828

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  7 in total

1.  Association of Spicy Food Consumption Frequency with Serum Lipid Profiles in Older People in China.

Authors:  K Yu; Y Xue; T He; L Guan; A Zhao; Y Zhang
Journal:  J Nutr Health Aging       Date:  2018       Impact factor: 4.075

2.  Metabolic factors and the risk of Dupuytren's disease: data from 30,000 individuals followed for over 20 years.

Authors:  Mattias Rydberg; Malin Zimmerman; Jin Persson Löfgren; Anders Gottsäter; Peter M Nilsson; Olle Melander; Lars B Dahlin
Journal:  Sci Rep       Date:  2021-07-19       Impact factor: 4.379

3.  Glucose and lipoprotein biomarkers and breast cancer severity using data from the Swedish AMORIS cohort.

Authors:  Jennifer C Melvin; Hans Garmo; Lars Holmberg; Niklas Hammar; Göran Walldius; Ingmar Jungner; Mats Lambe; Mieke Van Hemelrijck
Journal:  BMC Cancer       Date:  2017-04-04       Impact factor: 4.430

4.  The Significance of Apolipoprotein-A in the Long-Term Death of Patients with STEMI.

Authors:  Guoli Lin; Wen Chen; Caizhi Dai; Kaizu Xu
Journal:  J Healthc Eng       Date:  2022-01-15       Impact factor: 2.682

5.  Apolipoprotein A1 Enhances Endothelial Cell Survival in an In Vitro Model of ALS.

Authors:  Svitlana Garbuzova-Davis; Alison E Willing; Cesario V Borlongan
Journal:  eNeuro       Date:  2022-07-28

6.  Elevated ApoB/ApoA-I ratio is associated with acute anti-N-Methyl-D-aspartate receptor encephalitis, but not disease outcomes.

Authors:  Yingying Liu; Xiaomeng Ma; Lili Ma; Zhumin Su; Donghong Li; Xiaohong Chen
Journal:  Front Neurol       Date:  2022-09-01       Impact factor: 4.086

7.  Cardiovascular disease risk factor responses to a type 2 diabetes care model including nutritional ketosis induced by sustained carbohydrate restriction at 1 year: an open label, non-randomized, controlled study.

Authors:  Nasir H Bhanpuri; Sarah J Hallberg; Paul T Williams; Amy L McKenzie; Kevin D Ballard; Wayne W Campbell; James P McCarter; Stephen D Phinney; Jeff S Volek
Journal:  Cardiovasc Diabetol       Date:  2018-05-01       Impact factor: 9.951

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.